Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatoblastoma × Tissue Banks × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Peritoneal Diseases 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Diseases 1 Neuroblastoma 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatoblastoma 1 HER2 Positive Advanced Gastric Cancer 1 Fallopian Tube Neoplasms 1 Fallopian Tube Diseases 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 6 Granulocyte Colony-Stimulating Factor 5 Melphalan 4 Etoposide 4 Cisplatin 4 Carboplatin 4 sodium thiosulfate 3 fludarabine 3 Thiotepa 3 Mesna 3 Filgrastim 3 Busulfan 3 pembrolizumab 2 Vorinostat 2 Vincristine 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Ifosfamide 2 Gemcitabine 2 Fluorouracil 2 Doxorubicin 2 talazoparib 1 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 omburtamab I-131 1 lenvatinib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 etoposide phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn

Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡